Johnson & Johnson (JNJ) reported second-quarter adjusted EPS of $2.80, up 8.1% from a year ago. Adjusted operational sales were up 6.2% from a year ago. Operational growth excluding COVID-19 Vaccine was 8.9%, for the quarter.
from RTT - Earnings https://ift.tt/poVLYzm
via IFTTT
No comments:
Post a Comment